DrugDashboards

1% Lidocaine Hci

1% Lidocaine Hci · LIDOCAINE HYDROCHLORIDE 10 mg/mL · Injection, Solution · Infiltration; Perineural · HF Acquisition Co LLC, DBA HealthFirst

NDC 51662-1465-01 · 20 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA088299
TE code
AP
Approval date
Jul 31, 1984
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of 1% Lidocaine Hci (Injection, Solution)

LabelerStrengthFirst seenLast seen
HF Acquisition Co LLC, DBA HealthFirstLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "1% Lidocaine Hci — NDC 51662-1465-01," retrieved September 3, 2026, https://drugdashboards.com/drug/51662146501.

Free to cite with attribution — see how the data is put together.